Rohit Gautam, MD
Geriatric Medicine · van Buren, MENPI 1780994194
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 68 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 18 manufacturers reported payments, led by AbbVie at 26.4% of the total. Reporting peaked in 2023 at $489 and has fallen 57.5% since, to $208 in 2025. Among geriatric medicine clinicians in ME with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 68 payments — averaging $20.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$371
- Merck$185
- Pfizer$128
- Exact Sciences$113
- AstraZeneca$112
- Lilly USA, LLC$92
- plus $406 from 12 others
What the payments were for
- Food & beverage$1,406100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 17 | $371 |
| Merck | 8 | $185 |
| Pfizer | 6 | $128 |
| Exact Sciences | 5 | $113 |
| AstraZeneca | 6 | $112 |
| Lilly USA, LLC | 4 | $92 |
| Novo Nordisk | 5 | $87 |
| Scilex Pharmaceuticals Inc. | 3 | $56 |
| Boehringer Ingelheim | 3 | $48 |
| Abbott | 2 | $36 |
| GSK | 2 | $36 |
| Almatica Pharma LLC | 1 | $28 |
| Corium, LLC | 1 | $28 |
| CMP Pharma, Inc. | 1 | $21 |
| Johnson & Johnson | 1 | $19 |
| Dexcom, Inc. | 1 | $18 |
| Edwards Lifesciences | 1 | $17 |
| Novartis | 1 | $13 |
How this compares
$1,406 in reported general payments places this provider in the 95th percentile of 32 geriatric medicine providers in Maine.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 46 | $69,699 |
| MounjaroTirzepatide | 49 | $67,792 |
| FarxigaDapagliflozin Propanediol | 41 | $52,792 |
| JardianceEmpagliflozin | 24 | $32,149 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 29 | $29,640 |
| JanuviaSitagliptin Phosphate | 16 | $23,864 |
| EliquisApixaban | 16 | $15,634 |
| VascepaIcosapent Ethyl | 14 | $5,544 |
| SymbicortBudesonide/Formoterol Fumarate | 12 | $4,957 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 123 | $2,649 |
| Atorvastatin Calcium | 200 | $1,510 |
| Omeprazole | 105 | $1,489 |
| PaxlovidNirmatrelvir/Ritonavir | 15 | $1,429 |
| Gabapentin | 79 | $1,390 |
| Levothyroxine Sodium | 77 | $1,030 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $87 | $69,69946 claims |
| Lilly USA, LLCMounjaro | $92 | $67,79249 claims |
| AstraZenecaFarxiga, Symbicort | $112 | $57,74953 claims |
| Boehringer IngelheimJardiance | $48 | $32,14924 claims |
| GSKTrelegy Ellipta | $36 | $29,64029 claims |
| MerckJanuvia | $185 | $23,86416 claims |
| PfizerEliquis, Paxlovid | $128 | $17,06431 claims |
| Almatica Pharma LLCSertraline Hcl | $28 | $51760 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 32 geriatric medicine providers in Maine.
Other geriatric medicine in van Buren
- Ira StockwellWestbrook$1K
- Karen SaylorFreeport$277
- Alexandra BarrFreeport$239
- Carl SchulerWindham$211
- Rachel SluderPortland$164
- Jabbar FazeliBiddeford$145
- Michael IsaacTurner$119
- Ardis ConnerPortland$106
- Elizabeth Herskovits CastilloYork$101
- John RandPortland$80
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.